Specifically, a high infiltration of CD8+, CD4+, and CD3+ T lymphocytes localized in the margin and the core of the tumor has been correlated with a prolonged time in therapeutic range, increased OS, and DFS [37,38,39,40]. The gene discussed is CD4; the disease is neoplasm.